Filing Details

Accession Number:
0001209191-20-031880
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-22 19:59:04
Reporting Period:
2020-05-20
Accepted Time:
2020-05-22 19:59:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1333458 Joseph Robert Bujarski 9975 Summers Ridge Road
San Diego CA 92121
Svp, Na Comm Ops & Gen Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-20 20,000 $189.41 13,383 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The weighted average sale price for these transactions was $189.4141 per share, with a range of $185.705 to $191.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.